Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cegedim (C7E) Price & Analysis

C7E Stock Chart & Stats

€9.46-€0.09(-0.94%)
At close: 4:00 PM EDT
EUR 10EUR 10.59 Sep1 Oct28 Oct
Day’s Range
EUR 9.46 - EUR 9.51
52-Week Range
EUR 8.70 - EUR 14.15
Previous Close
EUR 9.55
Volume
150
Average Volume (3M)
74
Market Cap
EUR 133.03M
Enterprise Value
EUR 406.25M
Total Cash (Recent Filing)
EUR 49.58M
Total Debt (Recent Filing)
EUR 325.85M
Price to Earnings (P/E)
―
Beta
0.70
Next Earnings
Mar 25, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Business Model Diversification

Multiple, complementary revenue streams (subscriptions, transaction fees, consulting and data services) create durable cash inflows and reduce reliance on any single customer or product. This mix supports predictable recurring revenue and resilience through sector cycles in healthcare IT.

Recurring Revenue And Strategic Partners

High share of subscription-based services and partnerships with pharma and insurers increase client stickiness and recurring margins. Long-term contracts and institutional customers enable cross-sell, higher retention, and steadier revenue visibility over multiple quarters.

Consistent Revenue Growth Trend

Sustained top-line growth indicates ongoing demand for healthcare CRM, EHR and analytics. Steady revenue expansion provides a platform to scale gross margins, invest in product development, and pursue strategic initiatives without relying solely on cost cuts.

Bears Say

Negative Profitability

Recurring negative net income and shrinking EBIT margins threaten long-term sustainability; without margin recovery, the firm may struggle to self-fund R&D and growth initiatives, risking dilution or debt-funded expansion to maintain competitiveness.

Weakened Equity And Elevated Debt

A declining equity ratio and substantial total debt increase financial risk and limit strategic flexibility. Higher leverage raises refinancing and interest-rate vulnerability and could constrain investments, hiring, or M&A needed to defend market position.

Volatile Free Cash Flow

Operating cash generation is positive, but volatile free cash flow reduces capacity for consistent capital allocation. FCF swings complicate long-term planning for product investment, debt reduction, or returns to shareholders, weakening financial resilience.

Cegedim News

C7E FAQ

What was Cegedim’s price range in the past 12 months?
Cegedim lowest stock price was €8.70 and its highest was €14.15 in the past 12 months.
What is Cegedim’s market cap?
Cegedim’s market cap is €133.03M.
When is Cegedim’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cegedim’s earnings last quarter?
Cegedim released its earnings results on Sep 24, 2026. The company reported €0.397 earnings per share for the quarter.
Is Cegedim overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cegedim pay dividends?
Cegedim does not currently pay dividends.
What is Cegedim’s EPS estimate?
Cegedim’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cegedim have?
Cegedim has 14,097,155 shares outstanding.
What happened to Cegedim’s price movement after its last earnings report?
Cegedim reported an EPS of €0.397 in its last earnings report. Following the earnings report the stock price went up 3.499%.
Which hedge fund is a major shareholder of Cegedim?
Currently, no hedge funds are holding shares in DE:C7E
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology